KEVEN FAUST: Open Payments
NPI 1811530397 · BELTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $542 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $168 |
| GENZYME CORPORATION | 3 | $157 |
| UCB, Inc. | 4 | $98 |
| Amgen Inc. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Biofrontera Inc. | 1 | $21 |
Products named: DUPIXENT, Bimzelx, OTEZLA, COSENTYX, Zoryve, ADBRY, CIBINQO, RINVOQ.
Industry payments across TX — which companies pay providers there.
